# Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial

> **NCT07498374** · NA · RECRUITING · sponsor: **Tang-Du Hospital** · enrollment: 192 (estimated)

## Conditions studied

- Eosinophilic Chronic Rhinosinusitis With Nasal Polyps

## Interventions

- **DEVICE:** the fully degradable sinus stent
- **DRUG:** intranasal corticosteroids
- **DRUG:** oral corticosteroids

## Key facts

- **NCT ID:** NCT07498374
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-21
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 192 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07498374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07498374, "Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07498374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*